In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres
Abstract
Treatment of many intracellular infections in the mononuclear phagocytic system (MPS), requires targeting of antibiotics by a drug delivery system. The objective of this study was to examine whether the particular nature of microspheres, made of end-group capped and uncapped poly(lactide) [PLA] and poly(lactide-co-glycolide) [PLGA 50:50 and PLGA 75:25], affect the uptake into and also the activation of monocyte-macrophages. Placebo and gentamicin sulfate containing microspheres were incubated with J774 murine monocyte-macrophages and fresh human blood monocytes. Phagocytosis became more efficient with increasing polymer hydrophobicity, whereas opsonization of the particles in serum exerted inconsistent effects. Monocyte activation was determined by flow cytometry and measured as oxidative burst. The cellular oxidative burst induced by the particles was higher for end-group uncapped polymers. Opsonization increased significantly the oxidative activity of J774 monocytes, but affected inconsistently that of human blood monocytes. The results demonstrate that PLA and PLGA microspheres loaded with gentamicin sulfate were efficiently phagocytosed in vitro. The end-group uncapped polymer-type microspheres promoted significantly cell activation, which may be of importance for drug delivery and targeting to intracellular infections.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Particle structures smaller than 5 μm are taken up by APCs such as dendritic cells and macrophages and transported directly to the lymph node, where encapsulated antigen can be presented to T cells.
“Particle structures smaller than 5 μm are taken up by APCs, such as dendritic cells (DCs) and macrophages [59–61], and are transported directly to the lymph node [58], where the encapsulated antigen can be presented to T cells.”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [60]
Cites
Hansen, M., Nielsen, S. E., & Berg, K. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90397-9 · Cited by 3,526 · see citing works
Krevelen, D. W. V. (1990) · Cited by 3,264 · see citing works
Silverstein, S. C., Steinman, R. M., & Cohn, Z. A. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003321 · Cited by 1,290 · see citing works
Biodegradable polymers as drug delivery systems
(1992) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(92)90663-b · Cited by 777 · see citing works
Long circulating microparticulate drug carriers
Stolnik, S., Illum, L., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00025-3 · Cited by 702 · see citing works
MTT colorimetric assay for testing macrophage cytotoxic activity in vitro
Ferrari, M., Fornasiero, M. C., & Isetta, A. M. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90187-z · Cited by 566 · see citing works
Biodegradable polymers as drug delivery systems
Zhao, L. (1991) · European Journal of Medicinal Chemistry · doi:10.1016/0223-5234(91)90162-g · Cited by 514 · see citing works
One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate
Okada, H. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00050-1 · Cited by 373 · see citing works
Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption
Gessner, A., Waicz, R., Lieske, A., Paulke, B. ‐., Mäder, K., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00432-9 · Cited by 358 · see citing works
Controlled release of bioactive agents from lactide/glycolide polymers
Lewis, D. H. (1990) · Drugs and the pharmaceutical sciences · Cited by 358 · see citing works
Roser, M., Fischer, D., & Kissel, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00038-1 · Cited by 357 · see citing works
[8] Two-dimensional polyacrylamide gel electrophoresis
Dunn, M. J., & Corbett, J. M. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)71010-8 · Cited by 312 · see citing works
Leroux, J.-C., Allémann, E., De Jaeghere, F., Doelker, E., & Gurny, R. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00164-6 · Cited by 268 · see citing works
Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination
Johansen, P. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00079-5 · Cited by 210 · see citing works
Thomasin, C., Corradin, G., Men, Y., Merkle, H. P., & Gander, B. A. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01363-6 · Cited by 188 · see citing works
Self-citationSurface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages
Illum, L., Jacobsen, L., Müller, R. H., Mak, E., & Davis, S. S. (1987) · Biomaterials · doi:10.1016/0142-9612(87)90099-8 · Cited by 176 · see citing works
Szycher, M. (1992) · Journal of Clinical Engineering · doi:10.1097/00004669-199201000-00017 · Cited by 152 · see citing works
Évora, C., Soriano, I., Rogers, R. A., Shakesheff, K. M., Hanes, J. S., & Langer, R. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00149-1 · Cited by 147 · see citing works
Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections
Prior, S., Gamazo, C., Irache, J. M., Merkle, H. P., & Gander, B. A. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00448-2 · Cited by 128 · see citing works
Self-citationMacrophage-Pathogen Interactions
Zwilling, B. S., & Eisenstein, T. K. (1993) · Medical Entomology and Zoology · Cited by 120 · see citing works
Barrow, E. L. W., Winchester, G. A., Staas, J. K., Quenelle, D. C., & Barrow, W. W. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2682 · Cited by 113 · see citing works
Müller, R. H., Rühl, D., Lück, M., & Paulke, B. ‐. (1997) · Pharmaceutical Research · doi:10.1023/a:1012043131081 · Cited by 108 · see citing works
Advances in brucellosis research
Haesebrouck, F. (1991) · Veterinary Microbiology · doi:10.1016/0378-1135(91)90144-5 · Cited by 80 · see citing works
Advances in brucellosis research.
Adams, L. G. (1990) · Cited by 77 · see citing works
Lacasse, F.-X., Filion, M. C., Phillips, N. C., Escher, E., McMullen, J. N., & Hildgen, P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011935222652 · Cited by 72 · see citing works
Rudt, S., & Müller, R. H. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90101-v · Cited by 65 · see citing works
Wang, Y. M., Sato, H., & Horikoshi, I. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00082-5 · Cited by 61 · see citing works
Artursson, P., Arro, E., Edman, P., Ericsson, J. L. E., & Sjöholm, I. (1987) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600760209 · Cited by 51 · see citing works
Cruz, M. T., Gaspar, R. S., Donato, A., & Lopes, M. C. (1997) · Pharmaceutical Research · doi:10.1023/a:1012059501947 · Cited by 51 · see citing works
Vitas, A. I., Díaz, R., & Gamazo, C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.1.146 · Cited by 47 · see citing works
Self-citationProduction of active oxygen species by phagocytic leukocytes.
Robinson, J. M., & Badwey, J. A. (1994) · PubMed · Cited by 45 · see citing works
Lück, M., Schröder, W., Paulke, B. ‐., Blunk, T., & Müller, R. H. (1999) · Biomaterials · doi:10.1016/s0142-9612(99)00110-6 · Cited by 35 · see citing works
Seth (2009) · Cited by 34 · see citing works
Particle and Surface Characterisation Methods
Ortega-Martı́nez, R. (2000) · Archives of Medical Research · doi:10.1016/s0188-4409(00)00057-6 · Cited by 26 · see citing works
Zhang, Q., Gongtie, L., Wei, D., & NAGAI, T. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00395-5 · Cited by 23 · see citing works
Alveolar macrophage cell line is not activated by exposure to polymeric microspheres
Ng, K. Y., Stringer, K. A., Cohen, Z., Serravo, R., Tian, B., Meyer, J. D., Falk, R., Randolph, T. W., Manning, M. C., & Thompson, D. C. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00138-0 · Cited by 15 · see citing works
Formulation of Poly(DL-Lactide-Co-Glycolide) Microspheres and Their Ingestion by Bovine Leukocytes
O’Brien, C. N., & Guidry, A. J. (1996) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(96)76566-9 · Cited by 14 · see citing works
Morin, C., BARRATT, G. M., Fessi, H., Devissaguet, J. P., & Puisieux, F. (1993) · Journal of drug targeting · doi:10.3109/10611869308996072 · Cited by 13 · see citing works
Avgoustakis, K., & Nixon, J. R. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90366-n · Cited by 12 · see citing works
Deutsches Arzneibuch : Kommentar
Böhme, H., & Hartke, K. (1969) · Medical Entomology and Zoology · Cited by 10 · see citing works
Casado, J. A., Merino, J., Cid, J., Subirá, M. L., & Sánchez-Ibarrola, A. (1994) · PubMed Central · Cited by 9 · see citing works
Self-citation
Flagged first, then by citations
1 of the 42 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
Gaumet, M., Vargas, A., Gurny, R., & Delié, F. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.001 · Cited by 1,117 · see citing works
PLGA-Based Nanoparticles as Cancer Drug Delivery Systems
Mirakabad, F. S. T., Nejati‐Koshki, K., Akbarzadeh, A., Yamchi, M. R., Milani, M., Zarghami, N., Zeighamian, V., Rahimzadeh, A., Alimohammadi, S., Hanifehpour, Y., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.2.517 · Cited by 543 · see citing works
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
Dinarvand, R., Sepehri, N., Manouchehri, Rouhani, & Atyabi, F. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s18905 · Cited by 454 · see citing works
Formulation aspects of biodegradable polymeric microspheres for antigen delivery
Tamber, H., Johansen, P., Merkle, H. P., & Gander, B. A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.002 · Cited by 318 · see citing works
Self-citationPhysico-chemical features of engineered nanoparticles relevant to their toxicity
Fubini, B., Ghiazza, M., & Fenoglio, I. (2010) · Nanotoxicology · doi:10.3109/17435390.2010.509519 · Cited by 297 · see citing works
Pierigè, F., Serafini, S., Rossi, L., & Magnani, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.029 · Cited by 292 · see citing works
Joubert, M. K., Hokom, M. M., Eakin, C. M., Zhou, L., Deshpande, M., Baker, M., Goletz, T. J., Kerwin, B. A., Chirmule, N., Narhi, L. O., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.330902 · Cited by 268 · see citing works
Delivery systems to increase the selectivity of antibiotics in phagocytic cells
Briones, E., Colino, C. I., & Lanao, J. M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.027 · Cited by 226 · see citing works
Thiele, L., Merkle, H. P., & Walter, E. (2003) · Pharmaceutical Research · doi:10.1023/a:1022271020390 · Cited by 183 · see citing works
Self-citationHirota, K., Hasegawa, T., Hinata, H., Ito, F., Inagawa, H., Kochi, C., Soma, G., Makino, K., & Terada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.013 · Cited by 178 · see citing works
Inhaled drug therapy for treatment of tuberculosis
Misra, A., Hickey, A. J., Rossi, C. R., Borchard, G., Terada, H., Makino, K., Fourie, P. B., & Colombo, P. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.08.009 · Cited by 171 · see citing works
Konan, Y. N., Berton, M., Gurny, R., & Allémann, É. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00017-4 · Cited by 161 · see citing works
Brezden, A., Mohamed, M. F., Nepal, M., Harwood, J. S., Kuriakose, J., Seleem, M. N., & Chmielewski, J. A. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b04831 · Cited by 160 · see citing works
Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting
Gupta, U. D., & Jain, N. K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.018 · Cited by 156 · see citing works
Nanomedicine: Novel approaches in human and veterinary therapeutics
Irache, J. M., Esparza, I., Gamazo, C., Agüeros, M., & Espuelas, S. (2011) · Veterinary Parasitology · doi:10.1016/j.vetpar.2011.05.028 · Cited by 152 · see citing works
Self-citationCellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives.
Françoise Van Bambeke, A., Barcia-Macay, M., Lemaire, S., & Tulkens, P. M. (2006) · PubMed · Cited by 138 · see citing works
Drug loading and release on tumor cells using silk fibroin–albumin nanoparticles as carriers
Subia, B., & Kundu, S. C. (2012) · Nanotechnology · doi:10.1088/0957-4484/24/3/035103 · Cited by 136 · see citing works
Gheysoori, P., Paydayesh, A., Jafari, M. T., & Peidayesh, H. (2023) · European Polymer Journal · doi:10.1016/j.eurpolymj.2023.111846 · Cited by 120 · see citing works
Jilek, S., Merkle, H. P., & Walter, E. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.010 · Cited by 119 · see citing works
Self-citationNominally identical microplastic models differ greatly in their particle-cell interactions
Wieland, S., Ramsperger, A. F. R. M., Gross, W., Lehmann, M., Witzmann, T., Caspari, A., Obst, M., Gekle, S., Auernhammer, G. K., Fery, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45281-4 · Cited by 114 · see citing works
Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain
Milligan, E. D., Soderquist, R. G., Malone, S. M., Mahoney, J. H., Hughes, T., Langer, S. J., Sloane, E. M., Maier, S. F., Leinwand, L. A., Watkins, L. R., et al. (2006) · Neuron Glia Biology · doi:10.1017/s1740925x07000488 · Cited by 102 · see citing works
Mainardes, R. M., Gremião, M. P. D., Brunetti, I. L., da Fonseca, L. M., & Khalil, N. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21406 · Cited by 96 · see citing works
Essa, S., Rabanel, J., & Hildgen, P. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.039 · Cited by 94 · see citing works
Sharma, R., Muttil, P., Yadav, A. B., Rath, S. K., Bajpai, V. K., Mani, U., & Misra, A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl533 · Cited by 94 · see citing works
Lin, H., Gebhardt, M., Bian, S., Kwon, K. A., Shim, C., Chung, S.-J., & Kim, D. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.043 · Cited by 92 · see citing works
Soderquist, R. G., Sloane, E. M., Loram, L. C., Harrison, J. A., Dengler, E. C., Johnson, S. M., Amer, L. D., Young, C. S., Lewis, M., Poole, S., et al. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0077-y · Cited by 92 · see citing works
Sant, S., Poulin, S., & Hildgen, P. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31800 · Cited by 92 · see citing works
Development of HIV Reservoir Targeted Long Acting Nanoformulated Antiretroviral Therapies
Edagwa, B., Zhou, T., McMillan, J., Liu, X. M., & Gendelman, H. E. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140826114135 · Cited by 87 · see citing works
Application of Outer Membrane Protein-Based Vaccines Against Major Bacterial Fish Pathogens in India
Maiti, B., Dubey, S., Munang’andu, H. M., Karunasagar, I., Karunasagar, I., & Evensen, Ø. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01362 · Cited by 84 · see citing works
Dry powder inhalable formulations for anti-tubercular therapy
Parumasivam, T., Chang, R. Y. K., Abdelghany, S. M., Ye, T. T., Britton, W. J., & Chan, H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.011 · Cited by 80 · see citing works
Nanoparticle based Drug Delivery Systems for Treatment of Infectious Diseases
Salouti, M., & Ahangari, A. (2014) · InTech eBooks · doi:10.5772/58423 · Cited by 78 · see citing works
Imbuluzqueta, E., Elizondo, E., Gamazo, C., Moreno‐Calvo, E., Veciana, J., Ventosa, N., & Blanco‐Prieto, M. J. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.11.031 · Cited by 75 · see citing works
Self-citationAkagi, T., Shima, F., & Akashi, M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.049 · Cited by 73 · see citing works
Saito, E., Kuo, R., Kramer, K. R., Gohel, N., Giles, D. A., Moore, B. B., Miller, S. D., & Shea, L. D. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119432 · Cited by 72 · see citing works
Towards nanomedicines for neuroAIDS
Sagar, V., Pilakka‐Kanthikeel, S., Pottathil, R., Saxena, S. K., & Nair, M. (2014) · Reviews in Medical Virology · doi:10.1002/rmv.1778 · Cited by 71 · see citing works
Lecároz, C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl257 · Cited by 71 · see citing works
Wilson, D. S., Damo, M., Hirosue, S., Raczy, M. M., Brünggel, K., Diaceri, G., Quaglia-Thermes, X., & Hubbell, J. A. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0424-1 · Cited by 71 · see citing works
Luzardo-Alvarez, A., Blarer, N., Peter, K., Romero, J. F., Reymond, C., Corradin, G., & Gander, B. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.015 · Cited by 59 · see citing works
Self-citationLecároz, C., Campanero, M. Á., Gamazo, C., & Blanco‐Prieto, M. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl258 · Cited by 59 · see citing works
Self-citationParumasivam, T., Leung, S. S. Y., Quan, D. H., Triccas, J. A., Britton, W. J., & Chan, H. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.03.024 · Cited by 56 · see citing works
Fredriksen, B. N., Sævareid, K. L., McAuley, L., Lane, M. E., Bøgwald, J., & Dalmo, R. A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.087 · Cited by 56 · see citing works
Physicochemical Determinants in the Cellular Responses to Nanostructured Amorphous Silicas
Gazzano, E., Ghiazza, M., Polimeni, M., Bolis, V., Fenoglio, I., Attanasio, A., Mazzucco, G., Fubini, B., & Ghigo, D. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs128 · Cited by 56 · see citing works
Imbuluzqueta, E., Gamazo, C., Lana, H., Campanero, M. Á., Salas, D., Gil, A. G., Elizondo, E., Ventosa, N., Veciana, J., & Blanco‐Prieto, M. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00378-13 · Cited by 56 · see citing works
Self-citationMolecular aspects of microparticle phagocytosis by dendritic cells
Yoshida, M., & Babensee, J. E. (2006) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856206777996844 · Cited by 54 · see citing works
Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin
Lecároz, C., Gamazo, C., Renedo, M. J., & Blanco‐Prieto, M. J. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600946886 · Cited by 54 · see citing works
Self-citationJilek, S., Ulrich, M., Merkle, H. P., & Walter, E. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000033012.16152.5d · Cited by 53 · see citing works
Self-citationMatijevic, M., Hedley, M. L., Urban, R. G., Chicz, R. M., Lajoie, C., & Luby, T. M. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.04.005 · Cited by 51 · see citing works
Prior, S. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh227 · Cited by 51 · see citing works
Self-citationEnhanced passive pulmonary targeting and retention of PEGylated rigid microparticles in rats
Kutscher, H. L., Chao, P., Deshmukh, M., Rajan, S. S., Singh, Y., Hu, P., Joseph, L. B., Stein, S., Laskin, D. L., & Sinko, P. J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.09.020 · Cited by 47 · see citing works
Nanomedicine to fight infectious disease
Rubey, K. M., & Brenner, J. S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113996 · Cited by 47 · see citing works
Yadav, A. B., & Misra, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00925-07 · Cited by 46 · see citing works
Recent advances in delivery systems for anti-HIV1 therapy
Lanao, J. M., Briones, E., & Colino, C. I. (2007) · Journal of drug targeting · doi:10.1080/10611860600942178 · Cited by 44 · see citing works
Takeuchi, I., Taniguchi, Y., Tamura, Y., Ochiai, K., & Makino, K. (2017) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2017.10.047 · Cited by 41 · see citing works
Use of lectin-functionalized particles for oral immunotherapy
Diesner, S. C., Wang, X.-Y., Jensen-Jarolim, E., Untersmayr, E., & Gabor, F. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.146 · Cited by 40 · see citing works
Innate and adaptive immune responses in tissue engineering
Sefton, M. V., Babensee, J. E., & Woodhouse, K. A. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.12.008 · Cited by 40 · see citing works
Nanometrology: particle sizing and influence on the toxicological profile
Mota, W. S., Severino, P. B., Kadian, V., Rao, R., Zielińska, A., Silva, A. M., Mahant, S., & Souto, E. B. (2025) · Frontiers in Nanotechnology · doi:10.3389/fnano.2025.1479464 · Cited by 38 · see citing works
Mobarak, D. H., Salah, S., & Elkheshen, S. A. (2013) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2013.836293 · Cited by 38 · see citing works
Salari, F., Varasteh, A., Vahedi, F., Hashemi, M., & Sankian, M. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.09.011 · Cited by 37 · see citing works
Nanopolymersomes as potential carriers for rifampicin pulmonary delivery
Moretton, M. A., Cagel, M., Bernabeu, E., González, L., & Chiappetta, D. A. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.10.049 · Cited by 36 · see citing works
Gupta, M., Chashoo, G., Sharma, P. R., Saxena, A. K., Gupta, P. N., Agrawal, G. P., & Vyas, S. P. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400404p · Cited by 36 · see citing works
Imbuluzqueta, E., Lemaire, S., Gamazo, C., Elizondo, E., Ventosa, N., Veciana, J., Françoise Van Bambeke, A., & Blanco‐Prieto, M. J. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks172 · Cited by 36 · see citing works
Self-citationUpadhyay, T. K., Fatima, N., Sharma, A., Sharma, D., & Sharma, R. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1559180 · Cited by 35 · see citing works
Parikh, R. H., Dalwadi, S., Aboti, P. S., & Patel, L. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.13 · Cited by 35 · see citing works
Hasegawa, T., Hirota, K., Tomoda, K., Ito, F., Inagawa, H., Kochi, C., Soma, G., Makino, K., & Terada, H. (2007) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2007.06.017 · Cited by 35 · see citing works
Calcium‐Doped Organosilicate Nanoparticles as Gene Delivery Vehicles for Bone Cells
Moudgil, S., & Ying, J. Y. (2007) · Advanced Materials · doi:10.1002/adma.200701969 · Cited by 35 · see citing works
Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice
Prior, S. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki144 · Cited by 35 · see citing works
Self-citationTong, H.-I., Kang, W., Shi, Y., Zhou, G., & Lu, Y. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.03.028 · Cited by 34 · see citing works
Biggs, D. L., Lengsfeld, C., Hybertson, B. M., Ng, K., Manning, M. C., & Randolph, T. W. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00325-0 · Cited by 34 · see citing works
Vaccination Strategies against Malaria: novel carrier(s) more than a tour de force
Tyagi, R. K., Garg, N. K., & Sahu, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.037 · Cited by 33 · see citing works
Khan, W., & Kumar, N. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.492524 · Cited by 33 · see citing works
Sousa-Batista, A. J., Lima, W. P., Arruda-Costa, N., Falcão, C. A. B., Ré, M. I., & Rossi‐Bergmann, B. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01822-17 · Cited by 32 · see citing works
Shahbaz, S. K., Varasteh, A., Koushki, K., Ayati, S. H., Mashayekhi, K., Sadeghi, M., Moghadam, M., & Sankian, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106603 · Cited by 32 · see citing works
Verma, R. K., Agrawal, A. K., Singh, A. K., Mohan, M., Gupta, A., Gupta, P., Gupta, U. D., & Misra, A. (2013) · Tuberculosis · doi:10.1016/j.tube.2013.02.012 · Cited by 30 · see citing works
Yadav, A. B., Muttil, P., Singh, A. K., Verma, R. K., Mohan, M., Agrawal, A. K., Verma, A. S., Sinha, S. K., & Misra, A. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.03.001 · Cited by 30 · see citing works
Optimization of PLGA formulation containing protein or peptide‐based antigen: Recent advances
Hajavi, J., Ebrahimian, M., Sankian, M., Khakzad, M. R., & Hashemi, M. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36423 · Cited by 30 · see citing works
Gamazo, C., Prior, S., Lecároz, M. C., Vitas, A. I., Campanero, M. Á., Pérez, G., González, D., & Blanco‐Prieto, M. J. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.6.677 · Cited by 28 · see citing works
Self-citationO’Connor, G., Gleeson, L. E., Fagan-Murphy, A., Cryan, S., O’Sullivan, M. P., & Keane, J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.024 · Cited by 26 · see citing works
Korzhikov-Vlakh, V. A., Krylova, M., Sinitsyna, E., Ivan’kova, E. M., Averianov, I. V., & Tennikova, T. B. (2016) · Polymers · doi:10.3390/polym8120418 · Cited by 26 · see citing works
Effect of hesperidin conjugated with golden nanoparticles on phagocytic activity: In vitro study
Waheeb, H. M., Sulaiman, G. M., & Jabir, M. S. (2020) · AIP conference proceedings · doi:10.1063/5.0000159 · Cited by 25 · see citing works
Rosalia, R. A., Silva, A. L., Camps, M. G. M., Allam, A. A., Jiskoot, W., van der Burg, S. H., OSSENDORP, F. A., & Oostendorp, J. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1411-0 · Cited by 25 · see citing works
The internalization of fluorescence-labeled PLA nanoparticles by macrophages
Li, F., Zhu, A., Song, X., Ji, L., & Wang, J. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.033 · Cited by 25 · see citing works
Das, S., Khan, W., Mohsin, S., & Kumar, N. (2010) · Polymers for Advanced Technologies · doi:10.1002/pat.1710 · Cited by 24 · see citing works
Shrivastava, P., Gautam, L., Sharma, R. K., Dube, D., Vyas, S., & Vyas, S. P. (2020) · Journal of Microencapsulation · doi:10.1080/02652048.2020.1857861 · Cited by 22 · see citing works
Influence of the vehicle on the properties and efficacy of microparticles containing amphotericin B
Sánchez‐Brunete, J. A., Dea‐Ayuela, M. A., Rama, S., Bolás-Fernández, F., Alunda, J. M., Torrado, S., & Torrado, J. J. (2005) · Journal of drug targeting · doi:10.1080/10611860500097107 · Cited by 22 · see citing works
Tissue distribution of DNA-Hsp65/TDM-loaded PLGA microspheres and uptake by phagocytic cells
Trombone, A. P. F., Silva, C. L., de Almeida, L. P., Rosada, R. S., de Lima, K. M. C., Oliver, C., Jamur, M. C., & Coelho‐Castelo, A. A. M. (2007) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-5-9 · Cited by 21 · see citing works
Inhalable microparticles modify cytokine secretion by lung macrophages of infected mice
Sharma, R., Yadav, A. B., Muttil, P., Kajal, H., & Misra, A. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.11.003 · Cited by 20 · see citing works
Fatima, N., Upadhyay, T. K., Ahmad, F., Arshad, M., Kamal, M. A., Sharma, D., & Sharma, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118851 · Cited by 19 · see citing works
Phagocytosis of synthetic particulate vaccine delivery systems to program dendritic cells
Thiele, L., Merkle, H. P., & Walter, E. (2002) · Expert Review of Vaccines · doi:10.1586/14760584.1.2.215 · Cited by 19 · see citing works
Self-citationVerma, R. K., Singh, A. K., Mohan, M., Agrawal, A. K., & Misra, A. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.34 · Cited by 18 · see citing works
Hirota, K., Hasegawa, T., Nakajima, T., Makino, K., & Terada, H. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.05.032 · Cited by 17 · see citing works
Murillo, M., Irache, J. M., Estevan, M., Goñi, M. M., Blasco, J. M., & Gamazo, C. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.11.008 · Cited by 17 · see citing works
Self-citationActivation of antigen-presenting cells by DNA delivery vectors
Meng, W. S., & Butterfield, L. H. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.8.1019 · Cited by 17 · see citing works
Applications of Nanotechnology in Vaccine Delivery
Singh, A., Misra, R., Mohanty, C., & Sahoo, S. K. (2010) · doi:10.1080/1943085x.2010.488198 · Cited by 16 · see citing works
Multipolymer microsphere delivery of SARS-CoV-2 antigens
Shahjin, F., Patel, M., Machhi, J., Cohen, J. D., Nayan, M. U., Yeapuri, P., Zhang, C., Waight, E. M., Hasan, M., Abdelmoaty, M. M., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.12.043 · Cited by 15 · see citing works
Haque, S., Swami, P. N., & Khan, A. U. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105082 · Cited by 14 · see citing works
Javiya, C., & Jonnalagadda, S. (2016) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2016.1151030 · Cited by 13 · see citing works
Various carrier system(s)- mediated genetic vaccination strategies against malaria - Retracted
Tyagi, R. K., Sharma, P., Vyas, S. P., & Mehta, A. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.4.499 · Cited by 13 · see citing works
RetractedLemke-Miltner, C. D., Geary, S. M., Joshi, V. B., & Salem, A. K. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.030 · Cited by 12 · see citing works
León-Rodriguez, L., Leiro-Vidal, J., Blanco-Méndez, J., & Luzardo-Álvarez, A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.006 · Cited by 11 · see citing works
Innate and Adaptive Immune Responses in Tissue Engineering
Norton, L. W., & Babensee, J. E. (2009) · Springer eBooks · doi:10.1007/978-3-540-77755-7_50 · Cited by 11 · see citing works
- Authors
- Prior, S., Gander, B., Blarer, N., Merkle, H. P., Subirá, M. L., Irache, J. M., & Gamazo, C.
- Affiliations
- Universidad de Navarra (ES)
- ETH Zurich (CH)
- Corresponding author
- Gamazo, Carlos
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 15
- Issue
- 2
- Pages
- 197-207
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2057572412
- Cited by
- 138
- References
- 42
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 1 · 2016: 9 · 2015: 5 · 2014: 9 · 2013: 8 · 2012: 6
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Pharmaceutical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- polylactic acid, poly(lactic-co-glycolic acid), microspheres, phagocytosis, monocyte/macrophage activation, polymer hydrophobicity, opsonization, respiratory burst, gentamicin sulfate, intracellular drug delivery, J774 cells, blood monocytes
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Aminoglycosides, Animals, Biocompatible Materials, Cells, Cultured, Gentamicins, Humans, Macrophage Activation, Macrophages, Microspheres, Monocytes, Phagocytosis, Polyesters, Polyglycolic Acid, Polymers, Drug Delivery Systems, Respiratory Burst, Lactic Acid, Mice, Static Electricity, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review